Parkinson's disease is a recognisable and useful diagnostic entity
- PMID: 38267175
- DOI: 10.1016/S1474-4422(23)00512-4
Parkinson's disease is a recognisable and useful diagnostic entity
Erratum in
-
Correction to Lancet Neurol 2024; 23: 133-34.Lancet Neurol. 2024 Mar;23(3):e7. doi: 10.1016/S1474-4422(24)00049-8. Lancet Neurol. 2024. PMID: 38365386 No abstract available.
Conflict of interest statement
JAO reports research grants from the Spanish Ministry of Education and Science, the Focused Ultrasound Foundation, and the ASAP Coalition; has received honoraria for lecturing at meetings sponsored by BIAL, Insightec, and Esteve Pharmaceuticals; and serves in the safety advisory board of Biogen for trials in Parkinson's disease. PC receives or received research support, honoraria, and support to attend national and international conferences from AbbVie, Bayer Schering, Biogen-Dompè, Biogen, Eisai, Genzyme, Lundbeck, Lusofarmaco, Merck-Serono, Novartis, Prexton, Teva, UCB Pharma, and Zambon.
Comment on
-
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2. Lancet Neurol. 2024. PMID: 38267190 Review.
-
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria.Lancet Neurol. 2024 Feb;23(2):191-204. doi: 10.1016/S1474-4422(23)00404-0. Lancet Neurol. 2024. PMID: 38267191 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical